Introduction

Spinal cord injury (SCI) is a serious health problem, which places enormous psychological pressure and financial burden on patients’ families as well as on society.1 Studies have shown that the pathological course of SCI includes primary injury, that is, the direct mechanical effects on the spine, and secondary injury involving a complex cascade of molecular events, including disturbances in ion homeostasis, local oedema, focal haemorrhage, excitotoxicity, inflammatory responses and free radical stress.2 Furthermore, oxidative stress and apoptosis were shown to be important factors precipitating post-traumatic degeneration due to secondary destruction of the damaged spinal cord.3 Although the precise molecular pathway of secondary injury is still controversial, therapeutic strategies that inhibit or delay oxidative stress and apoptosis may contribute to SCI recovery.

Autophagy, a process used by cells to degrade cytosolic macromolecules and organelles in lysosomes, is generally considered a survival tactic to protect cells under conditions of stress (e.g., starvation, prooxidant conditions).4 Autophagy, which is a specific type of programmed cell death, is closely associated with, and shares some molecular events and regulators with, apoptosis.5 Recent evidence suggests a strong link between autophagy and SCI. Kanno H et al.6 first reported that autophagy is activated in the injured spinal cord. Furthermore, recent evidence suggests that stimulation of autophagy after SCI contributes to nerve cell self-protection and locomotive recovery.7

Calcitriol (C44H80O4Si2, also known as 1,25-dihydroxyvitamin D3), which has biological functions in bone and calcium metabolism, has a key role in osteoporosis. However, calcitriol has recently been shown to have a number of bioactivities. Recent studies indicated that calcitriol can depress oxidative stress status and prevent oxidative damage in renal ischaemia–reperfusion injury.8 Calcitriol attenuates levodopa-induced neurotoxicity in neural stem cells by significantly reducing apoptosis.9 In addition, calcitriol has been reported to upregulate the level of cellular autophagy.10 However, its relevance to promotion of functional recovery after SCI in rats has not been reported. In the present study, the effects of calcitriol on SCI and the underlying mechanism of action were explored.

Materials and methods

Animal preparations

Adult female Sprague–Dawley rats weighing 220–250 g were purchased from the Wenzhou Medical University (Wenzhou, China, SCXK[Zhe] 2005-0019). Animals were housed in a specific pathogen-free room with a 12 h light/dark cycle and fed with food and water regularly. The protocol for animal care and use conformed to the Guide for the Care and Use of Laboratory Animals from the National Institutes of Health and was approved by the Animal Care and Use Committee of Wenzhou Medical University (wydw2014–0129). All rats were randomly divided into three groups: a control group, an SCI group and a calcitriol group. Each group contained 30 rats.

Spinal cord injury

All animals in the three groups were anaesthetised using 2% pentobarbital sodium (40 mg kg−1; Solarbio Science & Technology, Beijing, China) by intraperitoneal injections. During the procedures, the temperature of the animals was recorded and maintained at 37 °C with a heating pad. The vertebral column was exposed and a laminectomy was carried out carefully at the T9 level and then compressed with a vascular clip (15 g force; Oscar, China) for 1 min; the exposed spinal cord was subjected to crushing injury. Rats in the control group were given the same surgical procedure, except compression injury, and the spinal cord was exposed for 1 min. After the SCI, manual urinary bladder emptying was performed three times daily until the return of the bladder function.

Drug administration

Calcitriol (Cayman, Ann Arbor, MI, USA) was dissolved in ethanol (1 mg ml−1) and further diluted in saline immediately prior to intraperitoneal (i.p.) administration. The calcitriol group (n=30) received calcitriol 2 μg kg−1 day−1 on 7 consecutive days. The control group (n=30) and the SCI group (n=30) received the equal amount of saline supplemented with the required volume of ethanol during 7 days. The animals received the first drug solution 2 h after the surgical procedure.

The Basso, Beattie and Bresnahan locomotion rating scale scores

The Basso, Beattie and Bresnahan (BBB) locomotion rating scale scores11 were used for the assessment of locomotion recovery of rats in different groups. Three, 7, 14, 21 and 28 days after the SCI, rats (n=6 per group) were laid on the floor, and crawling ability was observed for 5 min. Outcome measures were obtained in a blinded manner by independent examiners and averaged. In brief, the BBB scores range from 0 points, which indicates complete paralysis, to 21 points, which indicates normal locomotion.

The inclined plane test

The inclined plane test was performed via a method described before.12 In brief, all rats (n=6 per group) were tested in two positions (right side or left side up) on a testing apparatus (i.e., a board covered with a rubber mat containing horizontal ridges that were spaced 3 mm apart). For each position, the maximum angle at which a rat could maintain its position for 5 s without falling was recorded and averaged to obtain a single score for each rat.

Haematoxylin–eosin staining

Rats (n=6 per group) were re-anaesthetised with 2% (w/v) pentobarbital sodium (40 mg kg−1, i.p.) and perfused with normal saline, followed by 4% (w/v) paraformaldehyde in phosphate-buffered saline on the seventh day after surgery. Spinal cord segments (1 mm in length), which spanned a 3 mm length in the spinal cord centred at the epicentre, were collected and post-fixed in 4% (w/v) paraformaldehyde for 24 h. Then, samples in each group were embedded in paraffin for transverse paraffin sections. The paraffin sections (4 μm thick) mounted on poly-l-lysine-coated slides for histopathological examination by haematoxylin and eosin staining. In the end, HE staining was observed under light microscopy (Olympus, Tokyo, Japan).

Nissl staining

Spinal cord tissues (1 mm segments; n=6 per group) were excised and fixed, as before. The samples were embedded in paraffin for coronal paraffin sections. Paraffin sections (4 μm thick) were mounted on poly-l-lysine-coated slides for Nissl staining; coronal paraffin sections were deparaffinised with xylene and rehydrated through graded ethanol. After washing, the sections were blocked with 3% (v/v) H2O2 and treated with 10.2 mmol l−1 sodium citrate buffer for antigen retrieval for 20 min at 95 °C. After washing, sections were incubated in 1% (w/v) cresyl violet for Nissl staining and observed under a light microscope (Olympus). The Nissl-positive cells were automatically counted at six randomly selected fields from the lesion site per sample by using the Image-Pro Plus (IPP) software, version 6.0 (Media Cybernetics, Rockville, MD, USA).

Immunohistochemistry

Spinal cord tissues (1 mm segments; n=6 per group) were excised and fixed, as before. The samples were embedded in paraffin for coronal paraffin sections. Paraffin sections (4 μm thick) were mounted on poly-l-lysine-coated slides for immunohistochemistry; coronal paraffin sections were deparaffinised with xylene and rehydrated through graded ethanol. After washing, the sections were blocked with 3% (v/v) H2O2 and treated with 10.2 mmol l−1 sodium citrate buffer for antigen retrieval for 20 min at 95 °C. After blocking in 10% (v/v) bovine serum albumin dissolved in PBS for 30 min, sections were incubated with antibodies against Cleaved-caspase3 (C-caspase3; 1:500; Cell Signal Technology, Danvers, MA, USA) overnight at 4 °C. Next, sections were incubated with horseradish peroxidase-conjugated secondary antibodies for 2 h at 37 °C, developed with DAB and counterstained with haematoxylin. Images were captured at × 400 magnification under a light microscope (Olympus). The positive cells of C-caspase3 were counted automatically at six randomly selected fields from the lesion site per sample by using the IPP software.

TdT-mediated dUTP biotin nick-end labelling (TUNEL)

TUNEL was used to detect DNA fragmentation due to apoptotic signalling cascades. Coronal sections (n=6 per group) were washed with distilled water, incubated with proteinase K for 20 min at 37 °C and analysed using the In Situ Cell Death Detection Kit (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer’s instructions. Images were visualised using a fluorescence microscope (Olympus) at × 100 magnification, and the percentage of positive cells was quantified using five randomly selected fields per sample.

Transmission electron microscopy

After fixation in 2.5% (w/v) glutaraldehyde overnight, spinal cord tissues were post-fixed in 2% (v/v) osmium tetroxide and blocked with 2% (v/v) uranyl acetate. Following dehydration in a series of acetone washes, tissues were embedded in Araldite for coronal sections. Semithin section and toluidine blue staining were performed for observation of location. Finally, ultra-thin sections of at least three blocks per sample were cut and observed using Hitachi transmission electron microscopy.

Evaluation of superoxide dismutase activity and content of malondialdehyde and glutathione

Superoxide dismutase (SOD), malondialdehyde (MDA) and glutathione (GSH) testing kits (Nanjing Jiancheng Biology Institution, Nanjing, China) were used to detect the oxidative stress status of the injured spinal cord. On day 7 postoperatively, spinal cord tissues (n=6) were obtained from the lesion epicentre (2.5 mm cephalad and caudal), weighed, homogenised and diluted to 10% (vol/vol) in an ice bath. The homogenate was then centrifuged at 3500 r.p.m. for 10 min. Supernatant solution was collected to determine the following biochemical indices. SOD activity was detected using xanthine oxidase: homogenate (0.1 ml) was mixed with 1.4 ml xanthine oxidase and maintained in a water bath at 37 °C for 40 min. Developer (2.0 ml) was added for shade selection at 550 nm following a 10 min incubation at room temperature. MDA content was detected using modified thiobarbituric acid: homogenate (0.1 ml) was mixed with 0.1 ml dehydrated alcohol, 0.1 ml thiobarbituric acid and 4.0 ml developer, maintained in a water bath at 95 °C for 40 min, cooled in running water and centrifuged at 4000 r.p.m. for 10 min. The supernatant was obtained, and the absorbance was measured at 532 nm. GSH content was detected using modified dithiobisnitrobenzoicacid: homogenate (0.5 ml) was mixed with 2 ml dithiobisnitrobenzoicacid and centrifuged at 4000 for 10 min. The supernatant (1 ml) was obtained. After that, developer (1.55 ml) was added for shade selection at 420 nm following a 5 min incubation at room temperature.

Western blot analysis

Total proteins from spinal cord tissues were purified using protein extraction reagents. Rat spinal cord segments (8 mm; containing the injury epicentre) (n=6 per group) were dissected on day 7 following SCI. The equivalent of 60 μg protein was separated on a 12% (w/v) gel and transferred onto a PVDF membrane (Bio-Rad Laboratories, Hercules, CA, USA). After blocking with 5% (w/v) non-fat milk for 2 h, the membranes were incubated with the following antibodies: Bax, C-caspase3, Bcl2, Beclin1, p62 and GAPDH (1:1000; Cell Signaling Technology, Danvers, MA, USA), LC3 (1:500; Cell Signaling Technology). Next, the membranes were incubated with a goat-anti-rabbit secondary antibody for 2 h at room temperature, and bands were detected using the enhanced chemiluminescence (ECL) kit (PerkinElmer, Waltham, MA, USA). Band intensity was quantified using the Image Lab 3.0 software (Bio-Rad).

Statistical analysis

Statistical analyses were carried out using the SPSS.20 statistical software. All values are presented as the means±standard error of the mean (s.e.m.). Statistical evaluation of the data was performed by one-way analysis of variance followed by a post hoc comparison test using the least significant difference (equal variances assumed) or Dunnett’s T3 (equal variances not assumed) method. P-values <0.05 were considered to indicate statistical significance.

Results

Calcitriol attenuated oxidative stress in rats with SCI

SOD activity and the contents of MDA and GSH were measured to verify the antioxidant effects of calcitriol treatment 7 days after injury. Mean SOD activity and mean contents of MDA and GSH in each group (n=6 per group) were compared. In the rat spinal cord, the mean SOD activity and the mean level of GSH were decreased, whereas the mean MDA content was increased, at 7 days after injury. The calcitriol group had a much higher mean SOD activity (80.33±12.37 U mg−1 protein−1) compared with the SCI group (53.33±9.07 U mg−1 protein−1; P<0.05; Figure 1a). In addition, the mean GSH content in the calcitriol group was 6.98±1.99 nmol mg−1 protein−1 and that in the control group was 5.88±1.77 nmol mg−1 protein−1 (P<0.01) (Figure 1b). However, mean MDA content in the calcitriol group was 6.03±0.55 nmol mg−1 protein−1, which was significantly less than the value of 6.79±0.39 nmol mg−1protein−1 in the SCI group (P<0.05; Figure 1c).

Figure 1
figure 1

Calcitriol attenuated oxidative stress in rats with spinal cord injury (SCI). (a) The bar graph shows the mean level of superoxide dismutase (SOD) activity in spinal cord lesions in Control, SCI and Calcitriol groups. (b) The bar graph shows mean glutathione (GSH) content in the spinal cord lesions of the three groups. (c) The bar graph shows the mean malondialdehyde (MDA) levels in spinal cord lesions in the three groups. Data are expressed as means±s.e.m. (n=6 per group. *P<0.05 vs control group, #P<0.05 vs SCI group; The least significant difference test).

Calcitriol inhibited apoptosis in SCI rats

To assess the role of apoptosis in the injured spinal cord, TUNEL staining and immunohistochemistry were performed in each group. The green dots were regarded as TUNEL-positive cells (Figure 2a). No TUNEL-positive cells were detected in the lesions of the sham control group. In contrast, the SCI group showed a significant number of apoptosis-positive cells, with decreases seen in the calcitriol group (P<0.05; Figure 2c). Immunohistochemical analysis of apoptosis in SCI revealed significant decreases in the number of C-caspase3-positive cells in calcitriol-treated rats compared with SCI rats (P<0.05; Figures 2b and d). To quantify the level of apoptosis in the spinal cords of the three groups at 7 days after the operation, C-caspase3, Bax and Bcl2 expression levels were examined by western blotting analysis (Figure 2e). Compared with the SCI group, C-caspase3 and Bax expression levels were downregulated in the injured spinal cord of the calcitriol group (P<0.05; Figures 2f and g). Administration of calcitriol after SCI significantly increased Bcl2 levels (P<0.05; Figure 2h).

Figure 2
figure 2

Calcitriol inhibited apoptosis in SCI rats. (a) Representative immunofluorescent TUNEL (green) staining sections from the injured spinal cord in the Control group, the SCI group and the Calcitriol group. Nuclei are labelled with DAPI (blue) (original magnification × 200). (b) Immunohistochemistry for C-caspase3 in the three groups on day 7 after SCI (original magnification × 400). (c) The bar graph shows the numbers of TUNEL-positive cells in spinal cord lesions. (d) The bar graph shows the numbers of C-caspase3-positive cells in spinal cord lesions. (e) Protein expression of cleaved caspase3, Bcl2 and Bax in the injured spinal cords of the three groups. GAPDH was used as a loading control and for normalisation of band density. (f–h) Optical density analysis of C-caspase3, Bcl2 and Bax proteins in the three groups. Data are expressed as means±s.e.m. (n=6 per group. *P<0.05 vs control group, #P<0.05 vs SCI group; The least significant difference test).

Calcitriol upregulated autophagy in the injured spinal cord

We used transmission electron microscopy to observe autophagosomes—double membrane structures containing parts of cytoplasmic organelles—in the spinal cords of calcitriol rats (Figure 3a). To evaluate the effect of calcitriol treatment on the level of autophagy after SCI, we examined the levels of autophagy-associated protein expression at 7 days postoperatively by western blot analysis (Figure 3b). LC3-II, Beclin1 and p62 proteins are biomarkers for determining the level of cell autophagy. Administration of calcitriol after SCI significantly increased LC3-II and Beclin1 levels compared with the SCI group (P<0.05; Figures 3c and d). However, calcitriol treatment significantly reduced p62 expression (P<0.05; Figure 3e).

Figure 3
figure 3

Calcitriol upregulated autophagy levels in the injured spinal cord. (a) Transmission electron microscopy showed autophagosomes (black arrowheads) in the calcitriol group (original magnification × 7000 and × 20 000). (b) Protein expression of LC3-II, Beclin1 and p62 expression in the injured spinal cords of the three groups. GAPDH was used as the loading control and for band density normalisation. (ce) The optical density analysis of LC3-II, Beclin1 and p62 proteins in the three groups. Data were expressed as the mean±s.e.m. (n=6 per group. *P<0.05 vs control group, #P<0.05 vs SCI group; The least significant difference test).

Calcitriol reduced histological damage after SCI

Differences in histomorphology between the control, SCI and calcitriol groups were analysed by haematoxylin and eosin staining and Nissl staining 7 days after contusion. Progressive destruction of the dorsal white matter and central grey matter was evident in SCI rats relative to the control group, indicative of SCI. Comparisons between the SCI and calcitriol groups revealed significant beneficial effects, including decreased neuron loss and a smaller cavity involving the lateral funiculi, dorsal and central grey matter, in the calcitriol group (Figure 4a). Direct analysis of neuronal survival in the spinal cord was performed using Nissl staining 7 days after injury (Figure 4b). There were significantly fewer Nissl staining-positive cells in the spinal cord lesions of SCI rats. Furthermore, a smaller degree of loss of positively stained neurons was found in the lesions of calcitriol-treated SCI rats compared with the SCI group (P<0.05; Figure 4c).

Figure 4
figure 4

Calcitriol reduces histological damage after SCI. (a) Haematoxylin and eosin (H&E) staining of the injured spinal cords in the three groups to evaluate histological changes on day 7 day after SCI in the Control, SCI and Calcitriol groups (original magnification × 40 and × 200). (b) Nissl staining to assess the loss of neurons in the Control, SCI and Calcitriol groups (original magnification × 400), respectively. (c) The bar graph shows numbers of Nissl-positive cells in the spinal cord lesions in the three groups. Data are expressed as means±s.e.m. (n=6 per group. *P<0.05 vs control group, #P<0.05 vs SCI group; The least significant difference test).

Calcitriol improved locomotor functional recovery of rats receiving SCI

To evaluate the effects of calcitriol on locomotor functional recovery in rats after SCI, BBB scores and the angle of incline were measured on days 3, 7, 14, 21 and 28 postoperatively. As shown in Figure 5a, the differences in BBB scores between the SCI group and the calcitriol group on days 3 and 7 after SCI were not significant (P>0.05). However, BBB scores were significantly increased in calcitriol-treated rats on days 14, 21 and 28 after SCI compared with the SCI rats (P<0.05). As shown in Figure 5b, calcitriol significantly increased the angle of incline in the inclined plane test on days 7, 14, 21 and 28 days postoperatively. There was no significant difference in the BBB score on day 3 after SCI between the SCI group and the calcitriol group (P>0.05).

Figure 5
figure 5

Calcitriol improved functional recovery of rats after SCI. (a) The Basso, Beattie and Bresnahan (BBB) scores of rats in the Control group, the SCI group and the Calcitriol group on days 3, 7, 14, 21 and 28 after contusion. (b) The inclined plane test scores of these three groups at 3, 7, 14, 21 and 28 days after contusion. Data are expressed as means±s.d. (n=6 per group. *P<0.05 vs SCI group; The least significant difference test).

Discussion

In the present study, the angle of incline in the calcitriol group on day 7 was already significantly higher than that in the SCI alone group, whereas the BBB scores remained the same. The mild functional recovery could not be consistently observed in the early days of SCI, which is due to the characteristics of the BBB score and the inclined plane test. BBB scores could be used to assess the locations of claws, movement of the tail and other tiny movements of rat hindlimbs. The inclined plane test mainly focuses on assessment of myodynamia recovery in paraplegic rats. To more accurately assess the improvement of functional recovery in SCI after calcitriol treatment, a long-standing functional assessment was performed based on both the BBB score and the inclined plane test. In addition, we concluded that calcitriol significantly improves locomotor recovery after SCI in rats. The results of haematoxylin and eosin staining and Nissl staining indicated that calcitriol groups exhibited decreased neuron loss and a smaller cavity involving the lateral funiculi, as well as dorsal and central grey matter, after SCI—that is, the functional and histological recovery after SCI in rats showed significant improvements after treatment with calcitriol in the present study. These observations raise questions regarding the biological mechanism underlying the effect of calcitriol treatment in experimental SCI.

The pathological course of SCI includes both primary and secondary injury13 The primary injury to the spinal cord is followed by a long period of secondary injury. The levels of oxidative stress and apoptosis are believed to be two of the most important factors involved in post-traumatic degeneration due to destruction of the damaged spinal cord.3 Therefore, decreasing oxidation stress injury and inhibition of apoptosis are key factors in the therapeutic schedule of SCI. Calcitriol, that is 1,25-dihydroxyvitamin D3, is the biologically active metabolite of vitamin D and the predominant Ca2+-regulatory steroid hormone,14 which has a major role in osteoporosis. However, increasing numbers of studies indicate that calcitriol has many additional bioactivities. It was reported that calcitriol can significantly decrease apoptosis in levodopa—induced neural stem cell injury.9 In addition, similar therapeutic effects were confirmed in an in vitro model of Parkinson’s disease.10 Therefore, calcitriol treatment reduces the level of cell apoptosis in many diseases. Previous studies have shown that Bcl2 exerts an antiapoptotic effect,15 whereas Bax participates in the induction of apoptosis;16 activation of C-caspase3 is seen as a hallmark of apoptotic cell death, acting as the final executor of apoptosis.17 In the present study, western blotting analyses indicated lower levels of both C-caspase3 and Bax, whereas expression of Bcl2 was increased, in the calcitriol group relative to the SCI group. Furthermore, both immunohistochemistry for C-caspase3 and TUNEL staining showed significant decreases in the number of apoptosis-positive cells in the spinal cord lesions of calcitriol-treated rats. Therefore, we concluded that calcitriol can inhibit apoptosis in the damaged spinal cord.

MDA is the end product of lipid peroxidation, and the content of MDA is an indicator of free radical levels.18 GSH is a major intracellular antioxidant that evades free radicals and catalyses the dismutation of superoxide anions.19 The level of GSH reflects the ability to scavenge toxic free radicals.20 SOD is an extreme defence against oxygen-free radicals and is an indicator of antioxidant activity with the function of clearing O2 and preventing tissue injury by toxic oxygen-free radicals.21 Therefore, SOD activity and the levels of GSH and MDA are important biomarkers of oxidative stress status. Calcitriol has been shown to provide neuroprotection against ischaemia–reperfusion injury by decreasing the level of oxidative stress in the rat hippocampus.22 In the present study, we found that SOD activity and GSH content were markedly increased in the calcitriol group compared with controls, whereas the MDA level was decreased. Therefore, we verified that calcitriol suppresses oxidative stress in the damaged SCI.

Autophagy is essential for survival of cells under conditions of metabolic stress, and it is an intracellular degradation process involved in protein homeostasis. However, autophagy is also a specific type of programmed cell death.23 Although the role of autophagy in SCI is controversial, increasing numbers of investigations have demonstrated autophagy in rats and the feasibility of manipulating its expression to improve functional outcomes.24 Over the past few years, calcitriol has been reported to upregulate the level of autophagy—that is, it can induce autophagy in the SH-SY5Y neuroblastoma cell line as a model of Parkinson’s disease.7 In addition, calcitriol shows biochemical protective effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease through induction of autophagy.25 The present study showed the levels of LC3-II and Beclin1 proteins, representing increased autophagy flux, but the level of p62 protein, which was degraded through the autophagy–lysosomal pathway, decreased in the SCI rats treated with calcitriol compared with the SCI group. Therefore, calcitriol can upregulate the level of autophagy in the damaged spinal cord. It has been confirmed that promotion of autophagy confers a neuroprotective function in SCI.26 Moreover, oxidative stress injury can be relieved by autophagy, whereas apoptosis can be inhibited by the activation of autophagy. Therefore, the effects of calcitriol on attenuating oxidative stress and decreasing apoptosis after SCI in rats may be mediated through activation of autophagy.

Conclusion

In summary, our investigation demonstrated that locomotor recovery after SCI in rats showed significant improvements with calcitriol treatment, as confirmed by decreases in oxidative stress, inhibition of apoptosis and promotion of autophagy.

DATA ARCHIVING

There were no data to deposit.